´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-16±³À°ÀÏÀÚ : 2021-04-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ :
herz8@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 8 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ±³¼ö ¹× °³¿øÀÇ: 20000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ: 10000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 09:30~09:50 Optimal Choice and Duration of Antiplatelet Therapy in AMI Á¤¿µÈÆ(°æ»óÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 09:50~10:10 Timing of PCI for Nonculprit Lesion in STEMI ÃÖö¿õ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 10:10~10:30 Intracoronary Imaging-Guided PCI Can Improve Outcomes in AMI? À̼ºÀ±(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 10:30~10:50 Lipid Lowering Therapy in AMI: From Guidelines to Implementation Á¶°æÈÆ(Àü³²ÀÇ´ë)
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀÎ 10:50~11:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04¿ù 16ÀÏ 11:00~11:10 Break ()
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 11:10~11:20 Mechanisms and Risk Factors of AF ¹ÚÁø±Ô(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 11:20~11:30 AF screening: present and future ÀÌÁ¤¸í(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 11:30~11:40 Medical Rhythm Control for AF ¹ÚÇü¿í(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 11:40~11:50 Does Catheter Ablation of AF Improve Survival? ¾çÇʼº(Â÷ÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 11:50~12:00 Catheter Ablation of AF: Current Strategy ¹ÚÇü¼·(°è¸íÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 12:00~12:10 Update in Cryoablation of AF as An Initial Treatment ½ÉÀç¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 12:10~12:20 Treatment for Patients with AF and HF ¾È¹Î¼ö(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀÎ 12:20~12:40 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04¿ù 16ÀÏ 12:40~12:45 Break ()
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 12:45~13:05 How to Manage "Age Steven Deitelzweig(Ochsner. US)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 13:05~13:25 What Are the Characteristics of AF in Asian Patients? Addressing Issues and Challenges ±èÅÂÈÆ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 04¿ù 16ÀÏ 13:25~13:40 Break ()
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 12:45~14:30 Abstract/Case Session ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 14:30~14:45 Hypertension and AF: Pathophysiologic Considerations Á¶¿µÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 14:45~15:00 Blood Pressure Variability and New On AF ±ÇâÈñ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 15:00~15:15 Hypertension and AF: Preventive and Therapeutic Implications ÁøÀº¼±(°æÈñÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 15:15~15:30 Hypertension and AF: Epidemiology in Korea À̼ҷÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 15:30~15:45 Hypertension and AF: Special Considerations in the Elderly ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë)
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀÎ 15:45~16:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 04¿ù 16ÀÏ 16:00~16:10 Break ()
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 16:10~16:25 How to Assess Complex Congenital Heart Disease: Transthoracic Echocardiography ±è¿©Çâ(°æºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 16:25~16:40 Critical Moment with Tansesophageal Echocardiography À̽¾Æ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 16:40~16:55 Cardiac CT Imaging - Add-on Modality in ACHD Management °íÈÆ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 16:55~17:10 Right Ventricular Function and More - Cardiac MRI in ACHD ±è¿µÁø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 16ÀÏ ¿Â¶óÀÎ 17:10~17:25 Case Based Approach Using Multimodliaty Imaging in ACHD ¹ÚÁغó(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 16ÀÏ ¿Â¶óÀÎ 17:25~17:40 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)